Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.

Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E.

Transfusion. 2012 Dec;52(12):2671-6. doi: 10.1111/j.1537-2995.2012.03659.x.

PMID:
22519830
2.

Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease.

Michot JM, Driss F, Guitton C, Moh Klaren J, Lefebvre F, Chamillard X, Gallon P, Fourn E, Pela AM, Tertian G, Le Bras P, Chantalat-Auger C, Delfraissy JF, Goujard C, Lambotte O.

Transfusion. 2015 Feb;55(2):357-63. doi: 10.1111/trf.12875.

PMID:
25251746
3.

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.

Transfusion. 2002 Jan;42(1):37-43. Review.

PMID:
11896310
4.

Red blood cell alloimmunization in sickle cell disease patients in Uganda.

Natukunda B, Schonewille H, Ndugwa C, Brand A.

Transfusion. 2010 Jan;50(1):20-5. doi: 10.1111/j.1537-2995.2009.02435.x.

PMID:
19821949
5.

Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.

Godfrey GJ, Lockwood W, Kong M, Bertolone S, Raj A.

Pediatr Blood Cancer. 2010 Dec 1;55(6):1134-7. doi: 10.1002/pbc.22647.

PMID:
20979172
6.

Alloimmunization in sickle cell anemia in the era of extended red cell typing.

O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA.

Pediatr Blood Cancer. 2013 Sep;60(9):1487-91. doi: 10.1002/pbc.24530.

PMID:
23508932
7.

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.

PMID:
12777582
8.
9.

High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM.

Blood. 2013 Aug 8;122(6):1062-71. doi: 10.1182/blood-2013-03-490623.

10.

Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.

Kim HC, Dugan NP, Silber JH, Martin MB, Schwartz E, Ohene-Frempong K, Cohen AR.

Blood. 1994 Feb 15;83(4):1136-42.

11.

Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.

Adams DM, Schultz WH, Ware RE, Kinney TR.

J Pediatr Hematol Oncol. 1996 Feb;18(1):46-50.

PMID:
8556370
12.

The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults.

Kalff A, Dowsing C, Grigg A.

Br J Haematol. 2010 Jun;149(5):768-74. doi: 10.1111/j.1365-2141.2010.08150.x.

PMID:
20346014
13.

Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.

Venkateswaran L, Teruya J, Bustillos C, Mahoney D Jr, Mueller BU.

Pediatr Blood Cancer. 2011 Aug;57(2):294-6. doi: 10.1002/pbc.22985.

PMID:
21298771
14.

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.

Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B.

N Engl J Med. 1990 Jun 7;322(23):1617-21.

15.

Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.

Cox JV, Steane E, Cunningham G, Frenkel EP.

Arch Intern Med. 1988 Nov;148(11):2485-9.

PMID:
3142382
16.

Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.

Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, Wang W, Levy PS.

Blood. 1990 Oct 1;76(7):1431-7.

17.

[Transfusion and alloimmunization in sickle cell anemia patients].

Norol F, Nadjahi J, Bachir D, Desaint C, Guillou Bataille M, Beaujean F, Bierling P, Bonin P, Galacteros F, Duedari N.

Transfus Clin Biol. 1994;1(1):27-34. French.

PMID:
8186850
18.

[Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].

Diarra AB, Guindo A, Kouriba B, Dorie A, Diabaté DT, Diawara SI, Fané B, Touré BA, Traoré A, Gulbis B, Diallo DA.

Transfus Clin Biol. 2013 Dec;20(5-6):476-81. doi: 10.1016/j.tracli.2013.04.111. French.

PMID:
23916574
19.

Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)..

Transfusion. 2013 Apr;53(4):704-9. doi: 10.1111/j.1537-2995.2012.03796.x.

20.

Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.

Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A.

Transfusion. 2013 Apr;53(4):710-5. doi: 10.1111/j.1537-2995.2012.03819.x.

PMID:
22845746
Items per page

Supplemental Content

Support Center